Recombinant human platelet-derived growth factor-BB in human alveolar ridge augmentation: A review of the literature

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Purpose: The objective of this study was to review the available literature regarding the use of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in human alveolar ridge augmentation and to assess its effectiveness for this specific use. Materials and Methods: Three electronic searches of the MEDLINE database were performed. Results: This review noted a wide range of study protocols, carrier systems, study periods, and outcome measures. Conclusion: Within the limits of this literature review, the use of rhPDGF-BB and bone regeneration/ridge augmentation led to greater clinical attachment level gain and bone regeneration prior to implant placement. More controlled clinical studies are needed to establish the effectiveness of rhPDGF-BB in alveolar ridge augmentation.

Original languageEnglish (US)
Pages (from-to)1047-1056
Number of pages10
JournalInternational Journal of Oral and Maxillofacial Implants
Volume33
Issue number5
DOIs
StatePublished - Jan 1 2018

Keywords

  • alveolar ridge augmentation
  • Bone regeneration
  • Recombinant platelet-derived growth factor BB
  • RhPDGF-BB

ASJC Scopus subject areas

  • Oral Surgery

Fingerprint Dive into the research topics of 'Recombinant human platelet-derived growth factor-BB in human alveolar ridge augmentation: A review of the literature'. Together they form a unique fingerprint.

  • Cite this